On Friday, Shares of Dyax Corp. (NASDAQ:DYAX), surged 0.11% to $28.04.
Dyax Corp., will host a webcast and conference call, counting an open question and answer session, Wednesday, October 28, 2015. During the call, administration will discuss the Company’s financial results for the third quarter 2015 in addition to progress regarding its key value drivers – DX-2930, the KALBITOR® (ecallantide) business and the Licensing and Funded Research Portfolio (LFRP).
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. It offers KALBITOR for the treatment of acute attacks of HAE.
On other hand, Merck & Co. Inc. (NYSE:MRK) recently closed at market price of $51.48, up 1.50%, with a 1 year price target of $63.24. The company has a market cap of $145.00B. The forward P/E ratio is 13.63. The company gained volume of 11,073,358 shares exchanged hands Friday, as compared to its average daily volume of 12.63M shares.
Analysts mean recommendation for the stock is 2.40.
Merck & Co., known as MSD outside the United States and Canada, the American Diabetes Association and celebrity chef and cookbook author Leticia Moreinos Schwartz are bringing Desafiando la Diabetes: Logra Tus Metas to Houston. The program is designed to encourage Hispanics living with type 2 diabetes to know their A1C—their average blood glucose level over the past two to three months—and work with their doctor to set and reach their A1C aim. Through the program, Hispanics living with type 2 diabetes can also learn if they are at risk of low blood glucose, known as hypoglycemia, and how to assist reduce that risk.
In Texas, nearly 11 percent of the total adult population has been diagnosed with diabetes and it is a noteworthyconcern among Hispanic adults, as they are nearly twice as likely to be diagnosed with diabetes as non-Hispanic white adults. During her visit to Houston, Chef Leticia, who has a family history of type 2 diabetes and lost her grandfather to complications of the disease, will attend the American Diabetes Association’s EXPO on Oct. 17 at NRG Park Hall B, 8400 Kirby Drive. During the event, she will share some of her favorite Hispanic/Latino diabetes-friendly recipes and encourage people to make a pledge to know their A1C and work with their doctor to set and reach their A1C aim.
About one-third of adults living with diabetes are not at their A1C aim. The American Diabetes Association recommends that people with diabetes have an individualized A1C aim, which for many adults is less than 7 percent. Other people with diabetes may have a higher or lower A1C aim, so it is important they talk to their doctor about the aim that’s right for them. Adults with type 2 diabetes can assist reduce their risk of serious complications by setting individual aims to assist manage the ABCs of diabetes—A for A1C, also known as blood glucose, B for blood pressure and C for cholesterol.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
